DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

Income Statement DaShenLin Pharmaceutical Group Co., Ltd.

Stocks

603233

CNE100002RG2

Drug Retailers

End-of-day quote Shanghai S.E. Other stock markets 09/06/2026			5-day change	1st Jan Change
15.84 ^CNY	+0.32%		-4.98%	-10.10%

04-24	Dashenlin Pharma's Q1 Profit Rises 11%	MT
04-24	Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4%	MT

a613dc87de09f3441d2e07e1913d60.Pch6oczfxQ7ixjsF1O51CMZtcaWbWrXeZkjtGz1KSR4.eYoRyYKciFeFmWNwgZwFYoUGRffCFsWNBHiebWQ_H1ZOgBXm-LuBYYWndg

Published financial data: DASHENLIN PHARMACEUTICAL GROUP CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	16.29B	21.25B	23.93B	25.86B	26.85B
Other Revenues, Total	468M	-	600M	636M	657M
Total Revenues	16.76B	21.25B	24.53B	26.5B	27.5B
Cost of Goods Sold, Total	10.39B	13.23B	15.8B	17.42B	18.09B
Gross Profit	6.37B	8.02B	8.74B	9.07B	9.41B
Selling General & Admin Expenses, Total	5.19B	6.27B	6.81B	7.42B	7.21B
Provision for Bad Debts	11.49M	23.6M	15.92M	15.28M	13.42M
R&D Expenses	44.61M	74.38M	80.93M	51.68M	41.27M
Other Operating Expenses	29.94M	67.05M	35.32M	35.47M	105M
Other Operating Expenses, Total	5.27B	6.43B	6.94B	7.53B	7.37B
Operating Income	1.1B	1.59B	1.8B	1.55B	2.04B
Interest Expense, Total	-212M	-232M	-239M	-249M	-189M
Interest And Investment Income	77.7M	68.89M	91.75M	82.23M	69.6M
Net Interest Expenses	-134M	-163M	-148M	-167M	-120M
Currency Exchange Gains (Loss)	-	-	-	-	-701K
Other Non Operating Income (Expenses)	-29.15M	-48.52M	-49.85M	-46.32M	-34.45M
EBT, Excl. Unusual Items	938M	1.38B	1.6B	1.33B	1.88B
Impairment of Goodwill	-	-	-6.21M	-38.6M	-53.58M
Gain (Loss) On Sale Of Investments	34.57M	-18.71M	4.38M	10.61M	-1.52M
Gain (Loss) On Sale Of Assets	5.63M	18.73M	3.43M	19.21M	14.7M
Asset Writedown	-	-	-	-	-
Other Unusual Items	65.94M	38.84M	27.05M	13.89M	9.1M
EBT, Incl. Unusual Items	1.04B	1.41B	1.63B	1.34B	1.85B
Income Tax Expense	240M	336M	397M	360M	491M
Earnings From Continuing Operations	804M	1.08B	1.23B	980M	1.36B
Net Income to Company	804M	1.08B	1.23B	980M	1.36B
Minority Interest	-13.16M	-43.55M	-64.16M	-65.19M	-124M
Net Income - (IS)	791M	1.04B	1.17B	915M	1.24B
Net Income to Common Incl Extra Items	791M	1.04B	1.17B	915M	1.24B
Net Income to Common Excl. Extra Items	791M	1.04B	1.17B	915M	1.24B
Per Share Items
Net EPS - Basic	0.69	0.91	1.03	0.81	1.08
Basic EPS - Continuing Operations	0.69	0.91	1.03	0.81	1.08
Basic Weighted Average Shares Outstanding	1.14B	1.14B	1.13B	1.13B	1.14B
Net EPS - Diluted	0.69	0.91	1.03	0.81	1.08
Diluted EPS - Continuing Operations	0.69	0.91	1.03	0.81	1.08
Diluted Weighted Average Shares Outstanding	1.14B	1.14B	1.13B	1.13B	1.14B
Normalized Basic EPS	0.5	0.72	0.83	0.68	0.92
Normalized Diluted EPS	0.5	0.72	0.83	0.68	0.92
Dividend Per Share	0.35	0.5	0.31	0.62	0.83
Payout Ratio	67.53	40.58	51.82	82.34	63.32
Supplemental Items
EBITDA	1.3B	1.79B	2.02B	3.13B	2.3B
EBITA	1.11B	1.6B	1.81B	1.57B	2.06B
EBIT	1.1B	1.59B	1.8B	1.55B	2.04B
EBITDAR	1.31B	1.9B	2.09B	3.21B	2.38B
Total Revenues (As Reported)	16.76B	21.25B	24.53B	26.5B	27.5B
Effective Tax Rate - (Ratio)	22.94	23.72	24.4	26.85	26.52
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	289M	364M	421M	370M	477M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-49.77M	-28M	-23.7M	-10.64M	13.81M
Normalized Net Income	573M	816M	935M	769M	1.05B
Interest Capitalized	12.7M	18.71M	7.85M	7.17M	-
Interest on Long-Term Debt	225M	233M	224M	52.34M	-
Supplemental Operating Expense Items
Advertising Expense	-	-	30.81M	25.49M	-
Selling and Marketing Expenses	4.27B	5.16B	5.65B	6.22B	6.02B
General and Administrative Expenses	921M	1.11B	1.15B	1.21B	1.2B
Research And Development Expense From Footnotes	48.2M	78.41M	87.6M	51.68M	41.27M
Net Rental Expense, Total	11.26M	112M	73.78M	80.17M	79.32M
Imputed Operating Lease Interest Expense	6.07M	40.16M	23.45M	23.04M	17.78M
Imputed Operating Lease Depreciation	5.19M	72.05M	50.33M	57.13M	61.54M
Stock-Based Comp., G&A Exp. (Total)	65.63M	40.3M	19.04M	3.44M	-
Total Stock-Based Compensation	65.63M	40.3M	19.04M	3.44M	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.79B	4.49B	4.42B	6.22B	6.51B
Short Term Investments	-	-	-	6M	-
Trading Asset Securities, Total	109M	91.99M	41.99M	15.51M	439M
Total Cash And Short Term Investments	2.9B	4.59B	4.46B	6.24B	6.95B
Accounts Receivable, Total	744M	1.02B	1.23B	1.3B	1.28B
Other Receivables	366M	368M	437M	400M	407M
Total Receivables	1.11B	1.39B	1.67B	1.7B	1.69B
Inventory	3.63B	3.87B	4.18B	4.13B	4.14B
Prepaid Expenses	2.41M	39.03M	11.97M	24.75M	3.86M
Other Current Assets, Total	224M	783M	476M	492M	599M
Total Current Assets	7.87B	10.67B	10.8B	12.59B	13.38B
Gross Property Plant And Equipment	8.85B	9.8B	11.56B	12.1B	11.86B
Accumulated Depreciation	-3.2B	-3.71B	-4.26B	-4.8B	-5.1B
Net Property Plant And Equipment	5.65B	6.09B	7.3B	7.31B	6.76B
Long-term Investments	150M	132M	156M	156M	158M
Goodwill	2.06B	2.36B	3.02B	3.52B	3.47B
Other Intangibles, Total	619M	637M	1.86B	1.97B	1.97B
Deferred Tax Assets Long-Term	158M	186M	214M	232M	218M
Deferred Charges Long-Term	670M	663M	670M	648M	515M
Other Long-Term Assets, Total	158M	94.19M	101M	22.22M	21.79M
Total Assets	17.34B	20.84B	24.12B	26.44B	26.49B
Liabilities
Accounts Payable, Total	4.74B	6.13B	6.87B	8.43B	9.94B
Accrued Expenses, Total	489M	810M	758M	686M	691M
Short-term Borrowings	165M	697M	745M	1.98B	543M
Current Portion of Long-Term Debt	-	7.64M	14.84M	42.28M	1.43B
Current Portion of Leases	906M	975M	1.04B	1.18B	1.11B
Current Income Taxes Payable	98.67M	138M	176M	138M	199M
Unearned Revenue Current, Total	164M	436M	362M	409M	478M
Other Current Liabilities	615M	517M	1.49B	840M	677M
Total Current Liabilities	7.18B	9.71B	11.45B	13.71B	15.07B
Long-Term Debt	1.25B	1.46B	1.64B	1.85B	463M
Long-Term Leases	2.95B	2.79B	3.07B	2.7B	2.23B
Unearned Revenue Non Current	20.12M	17.64M	19.3M	17.42M	14.98M
Other Non Current Liabilities	-	328K	9.67M	34.84M	53.42M
Total Liabilities	11.4B	13.98B	16.19B	18.3B	17.83B
Common Stock, Total	791M	949M	1.14B	1.14B	1.14B
Additional Paid In Capital	1.64B	1.54B	1.35B	1.29B	1.26B
Retained Earnings	2.93B	3.57B	4.17B	4.38B	4.88B
Treasury Stock	-77.59M	-36.68M	-29.72M	-101M	-101M
Comprehensive Income and Other	190M	190M	190M	190M	190M
Total Common Equity	5.48B	6.21B	6.82B	6.9B	7.37B
Minority Interest	457M	652M	1.11B	1.24B	1.29B
Total Equity	5.94B	6.86B	7.93B	8.14B	8.66B
Total Liabilities And Equity	17.34B	20.84B	24.12B	26.44B	26.49B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.14B	1.14B	1.14B	1.14B	1.14B
ECS Total Common Shares Outstanding	1.14B	1.14B	1.14B	1.14B	1.14B
Book Value / Share	4.81	5.45	5.99	6.06	6.47
Tangible Book Value	2.8B	3.21B	1.94B	1.41B	1.93B
Tangible Book Value Per Share	2.46	2.82	1.7	1.23	1.7
Total Debt	5.28B	5.93B	6.51B	7.74B	5.78B
Net Debt	2.37B	1.35B	2.05B	1.51B	-1.17B
Debt Equivalent Oper. Leases	90.08M	898M	590M	641M	635M
Minority Interest, Total (Incl. Fin. Div)	457M	652M	1.11B	1.24B	1.29B
Equity Method Investments, Total	188K	142K	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	164M	163M	178M	96.3M	94.79M
Inventories - Work In Process, Total	34.11M	38.01M	31.05M	50.77M	34.78M
Inventories - Finished Goods, Total	3.45B	3.68B	3.98B	3.97B	3.99B
Inventories - Others	-	-	61.98M	35.08M	44.86M
Buildings, Total	800M	1.08B	2.02B	2.66B	-
Machinery, Total	1.12B	1.26B	1.46B	1.6B	1.76B
Full Time Employees	38.35K	39.5K	45.47K	43.53K	41.14K
Accumulated Allowance for Doubtful Accounts (Supple)	45.22M	59.89M	72.43M	76.96M	68.4M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	791M	1.04B	1.17B	915M	1.24B
Depreciation & Amortization - CF	1.13B	1.26B	1.41B	1.56B	1.5B
Amortization of Goodwill and Intangible Assets - (CF)	9.58M	10.3M	18.38M	23.58M	20.13M
Depreciation & Amortization, Total	1.14B	1.27B	1.43B	1.58B	1.52B
Amortization of Deferred Charges, Total - (CF)	228M	260M	267M	311M	270M
(Gain) Loss From Sale Of Asset	-5.63M	-18.73M	-3.43M	-19.21M	-14.7M
(Gain) Loss on Sale of Investments - (CF)	-44M	12.89M	-10.94M	-11.57M	6.81M
Asset Writedown & Restructuring Costs	-	-	6.21M	38.6M	53.58M
Provision and Write-off of Bad Debts	11.49M	23.6M	15.92M	15.28M	13.42M
Other Operating Activities, Total	247M	294M	388M	348M	342M
Change In Accounts Receivable	-318M	-953M	-365M	-1.59B	304M
Change In Inventories	-746M	-157M	-104M	126M	-40.93M
Change In Accounts Payable	235M	1.97B	389M	1.4B	1.64B
Change In Deferred Taxes	-49.74M	-28M	-23.7M	-10.64M	13.81M
Change in Other Net Operating Assets	65.63M	48.54M	19.04M	3.28M	-
Cash from Operations	1.55B	3.76B	3.17B	3.11B	5.35B
Capital Expenditure	-1.29B	-1.03B	-1.8B	-1.48B	-486M
Sale of Property, Plant, and Equipment	21.61M	37.37M	14.64M	28.53M	29.36M
Cash Acquisitions	-530M	-305M	-502M	-521M	-93.97M
Divestitures	-	-	-	1.59M	-1.73M
Investment in Marketable and Equity Securities, Total	814M	5.54M	-2.16M	11.34M	-422M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-5M	-	-
Other Investing Activities, Total	21.35M	3.17M	-11.8M	15.86M	3.53M
Cash from Investing	-968M	-1.29B	-2.3B	-1.94B	-970M
Short Term Debt Issued, Total	146M	-	16M	192M	72.15M
Long-Term Debt Issued, Total	-	1.1B	1.09B	3.14B	893M
Total Debt Issued	146M	1.1B	1.11B	3.33B	965M
Short Term Debt Repaid, Total	-223M	-	-4.9M	-	-
Long-Term Debt Repaid, Total	-1.1B	-1.66B	-2.39B	-3.42B	-3.8B
Total Debt Repaid	-1.32B	-1.66B	-2.39B	-3.42B	-3.8B
Issuance of Common Stock	13.25M	-	-	-	-
Repurchase of Common Stock	-436K	-110K	-946K	-102M	-
Common Dividends Paid	-534M	-420M	-605M	-753M	-782M
Common & Preferred Stock Dividends Paid	-534M	-420M	-605M	-753M	-782M
Other Financing Activities, Total	84.37M	46.98M	238M	15.52M	-81.96M
Cash from Financing	-1.61B	-934M	-1.65B	-932M	-3.7B
Foreign Exchange Rate Adjustments	-	-	-	320K	-701K
Net Change in Cash	-1.02B	1.53B	-779M	235M	681M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	898M	939M	1.11B	1.27B	1.39B
Levered Free Cash Flow	413M	2.19B	2.26B	2.08B	3.86B
Unlevered Free Cash Flow	545M	2.33B	2.41B	2.23B	3.97B
Change In Net Working Capital	281M	-805M	-1.37B	-844M	-1.39B
Net Debt Issued / Repaid	-1.17B	-560M	-1.28B	-92.44M	-2.83B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.64	5.2	4.99	3.83	4.81
Return on Total Capital	7.57	8.27	8.24	6.38	8.39
Return On Equity %	13.98	16.86	16.63	12.19	16.18
Return on Common Equity	14.57	17.72	17.9	13.33	17.32
Margin Analysis
Gross Profit Margin %	38.03	37.76	35.61	34.25	34.22
SG&A Margin	30.95	29.51	27.75	28.02	26.23
EBITDA Margin %	7.73	8.42	8.22	11.82	8.37
EBITA Margin %	6.63	7.52	7.4	5.93	7.48
EBIT Margin %	6.57	7.47	7.32	5.84	7.4
Income From Continuing Operations Margin %	4.8	5.08	5.02	3.7	4.94
Net Income Margin %	4.72	4.87	4.76	3.45	4.49
Net Avail. For Common Margin %	4.72	4.87	4.76	3.45	4.49
Normalized Net Income Margin	3.42	3.84	3.81	2.9	3.82
Levered Free Cash Flow Margin	2.46	10.3	9.22	7.84	14.02
Unlevered Free Cash Flow Margin	3.25	10.99	9.83	8.43	14.45
Asset Turnover
Asset Turnover	1.13	1.11	1.09	1.05	1.04
Fixed Assets Turnover	4.83	3.62	3.66	3.63	3.91
Receivables Turnover (Average Receivables)	27.7	24.07	21.22	20.39	20.77
Inventory Turnover (Average Inventory)	3.29	3.53	3.92	4.19	4.38
Short Term Liquidity
Current Ratio	1.1	1.1	0.94	0.92	0.89
Quick Ratio	0.56	0.62	0.54	0.58	0.57
Operating Cash Flow to Current Liabilities	0.22	0.39	0.28	0.23	0.36
Days Sales Outstanding (Average Receivables)	13.18	15.17	17.2	17.95	17.57
Days Outstanding Inventory (Average Inventory)	110.93	103.53	93.05	87.28	83.41
Average Days Payable Outstanding	144.17	147.23	147.3	161.24	185.17
Cash Conversion Cycle (Average Days)	-20.06	-28.54	-37.04	-56.01	-84.18
Long Term Solvency
Total Debt/Equity	88.87	86.41	82.04	95.16	66.68
Total Debt / Total Capital	47.05	46.35	45.07	48.76	40
LT Debt/Equity	70.82	61.94	59.34	55.82	31.05
Long-Term Debt / Total Capital	37.5	33.23	32.6	28.6	18.63
Total Liabilities / Total Assets	65.76	67.06	67.11	69.22	67.3
EBIT / Interest Expense	5.19	6.84	7.51	6.22	10.75
EBITDA / Interest Expense	10.57	12.33	13.48	12.58	18.8
(EBITDA - Capex) / Interest Expense	4.46	7.87	5.97	6.65	16.24
Total Debt / EBITDA	2.35	2.07	2.02	2.47	1.62
Net Debt / EBITDA	1.06	0.47	0.64	0.48	-0.33
Total Debt / (EBITDA - Capex)	5.58	3.25	4.56	4.68	1.88
Net Debt / (EBITDA - Capex)	2.51	0.74	1.44	0.91	-0.38
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.92	26.78	15.45	8.01	3.8
Gross Profit, 1 Yr. Growth %	14.03	25.86	8.9	3.87	3.7
EBITDA, 1 Yr. Growth %	-15.49	37.05	11.52	-3.49	26.22
EBITA, 1 Yr. Growth %	-19.12	42.56	12.28	-14.33	29.31
EBIT, 1 Yr. Growth %	-19.18	44.16	12.98	-13.86	31.55
Earnings From Cont. Operations, 1 Yr. Growth %	-25.73	34.17	14.03	-20.37	38.67
Net Income, 1 Yr. Growth %	-25.51	30.9	12.63	-21.58	35.04
Normalized Net Income, 1 Yr. Growth %	-32.37	42.51	14.34	-17.79	36.79
Diluted EPS Before Extra, 1 Yr. Growth %	-25.93	29.76	13.19	-21.36	33.33
Accounts Receivable, 1 Yr. Growth %	72.05	37.37	20.77	5.61	-1.69
Inventory, 1 Yr. Growth %	35.33	6.68	7.97	-1.27	0.32
Net Property, Plant and Equip., 1 Yr. Growth %	339.24	7.8	19.79	0.06	-7.47
Total Assets, 1 Yr. Growth %	40.58	20.22	15.75	9.6	0.18
Tangible Book Value, 1 Yr. Growth %	-21.37	14.68	-39.55	-27.55	37.52
Common Equity, 1 Yr. Growth %	1.74	13.38	9.85	1.08	6.82
Cash From Operations, 1 Yr. Growth %	-20.42	141.58	-15.51	-2.13	72.24
Capital Expenditures, 1 Yr. Growth %	63.44	-20.09	73.62	-17.86	-67.19
Levered Free Cash Flow, 1 Yr. Growth %	-44.26	430.76	3.2	-8.09	85.93
Unlevered Free Cash Flow, 1 Yr. Growth %	-27.06	328.31	3.19	-7.34	78.27
Dividend Per Share, 1 Yr. Growth %	-25.01	43.97	-38	100	33.87
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	22.65	20.71	20.99	11.67	5.88
Gross Profit, 2 Yr. CAGR %	20.51	19.8	17.07	6.36	3.79
EBITDA, 2 Yr. CAGR %	10.62	8.04	24.26	31.59	-15.76
EBITA, 2 Yr. CAGR %	9.38	7.86	27.25	-1.41	5.88
EBIT, 2 Yr. CAGR %	9.63	7.94	27.72	-1.35	6.45
Earnings From Cont. Operations, 2 Yr. CAGR %	7.46	-0.17	23.69	-4.71	5.08
Net Income, 2 Yr. CAGR %	6.12	-1.25	21.42	-6.02	2.9
Normalized Net Income, 2 Yr. CAGR %	0.26	-1.83	27.77	-3.05	6.05
Diluted EPS Before Extra, 2 Yr. CAGR %	4.44	-1.57	21.3	-5.65	2.4
Accounts Receivable, 2 Yr. CAGR %	44.61	53.74	28.8	12.93	1.9
Inventory, 2 Yr. CAGR %	32.91	20.15	7.32	3.25	-0.48
Net Property, Plant and Equip., 2 Yr. CAGR %	124.76	117.61	13.64	9.48	-3.78
Total Assets, 2 Yr. CAGR %	41.39	30	17.96	12.63	4.78
Tangible Book Value, 2 Yr. CAGR %	-1.81	-5.04	-16.74	-33.82	-0.19
Common Equity, 2 Yr. CAGR %	13.67	7.41	11.6	5.37	3.91
Cash From Operations, 2 Yr. CAGR %	-4.58	38.66	42.87	-9.07	29.83
Capital Expenditures, 2 Yr. CAGR %	60.71	14.28	17.79	19.42	-48.01
Levered Free Cash Flow, 2 Yr. CAGR %	-37.39	72	134.12	-2.61	30.58
Unlevered Free Cash Flow, 2 Yr. CAGR %	-28.71	76.75	110.31	-2.22	28.39
Dividend Per Share, 2 Yr. CAGR %	9.55	3.92	-5.52	11.36	63.63
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	23.68	24.01	18.93	16.5	8.98
Gross Profit, 3 Yr. CAGR %	20.06	22.27	16.05	12.5	5.46
EBITDA, 3 Yr. CAGR %	15.95	19.12	9.56	33.84	8.38
EBITA, 3 Yr. CAGR %	15.3	19.84	9.74	11.91	8.35
EBIT, 3 Yr. CAGR %	15.53	20.11	9.65	12.01	8.58
Earnings From Cont. Operations, 3 Yr. CAGR %	15.23	15.72	4.35	6.8	7.98
Net Income, 3 Yr. CAGR %	14.17	13.81	3.17	4.95	6.05
Normalized Net Income, 3 Yr. CAGR %	8.64	12.73	3.35	10.3	8.74
Diluted EPS Before Extra, 3 Yr. CAGR %	12.18	12.58	3.19	4.99	5.88
Accounts Receivable, 3 Yr. CAGR %	38.11	42.16	41.85	20.55	7.83
Inventory, 3 Yr. CAGR %	24.39	23.52	15.95	4.38	2.26
Net Property, Plant and Equip., 3 Yr. CAGR %	79.16	75.94	78.34	8.92	3.51
Total Assets, 3 Yr. CAGR %	38.42	33.95	25.06	15.11	8.32
Tangible Book Value, 3 Yr. CAGR %	7.8	3.4	-18.31	-20.51	-15.55
Common Equity, 3 Yr. CAGR %	21.72	13.58	8.21	7.98	5.85
Cash From Operations, 3 Yr. CAGR %	21.19	30.05	17.55	25.94	12.51
Capital Expenditures, 3 Yr. CAGR %	32.68	27.32	31.38	4.45	-22.29
Levered Free Cash Flow, 3 Yr. CAGR %	8.58	27.66	45.11	71.43	20.73
Unlevered Free Cash Flow, 3 Yr. CAGR %	17.36	29.6	47.76	60.03	19.37
Dividend Per Share, 3 Yr. CAGR %	15.97	20.01	-12.52	21.31	18.4
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	21.72	23.42	22.59	18.92	13.53
Gross Profit, 5 Yr. CAGR %	20.39	21.91	18.86	15.64	10.98
EBITDA, 5 Yr. CAGR %	14.4	19.72	19.39	24.21	8.47
EBITA, 5 Yr. CAGR %	12.69	19.48	20.15	11.09	8.4
EBIT, 5 Yr. CAGR %	12.68	19.55	20.26	11.05	8.36
Earnings From Cont. Operations, 5 Yr. CAGR %	13.42	17.86	18.54	7.07	4.64
Net Income, 5 Yr. CAGR %	12.96	16.87	17.02	5.42	3.06
Normalized Net Income, 5 Yr. CAGR %	9.5	15.65	15.92	6.17	4.42
Diluted EPS Before Extra, 5 Yr. CAGR %	9.49	14.21	15.93	4.94	2.87
Accounts Receivable, 5 Yr. CAGR %	29.18	32.89	34.31	29.66	24.27
Inventory, 5 Yr. CAGR %	22.71	17.67	17.26	14.97	9.07
Net Property, Plant and Equip., 5 Yr. CAGR %	55.33	50.04	49.33	45.53	39.34
Total Assets, 5 Yr. CAGR %	37.09	29.05	29.84	24.98	16.52
Tangible Book Value, 5 Yr. CAGR %	20.02	5.33	-2.78	-13.5	-11.49
Common Equity, 5 Yr. CAGR %	32.98	17.68	17.57	10.22	6.47
Cash From Operations, 5 Yr. CAGR %	25.7	42.12	29.43	12.71	22.32
Capital Expenditures, 5 Yr. CAGR %	33.33	9.13	26.51	24.1	-9.33
Levered Free Cash Flow, 5 Yr. CAGR %	17.16	206.44	47.65	14.57	39.11
Unlevered Free Cash Flow, 5 Yr. CAGR %	22.81	160.21	48.2	15.8	39.68
Dividend Per Share, 5 Yr. CAGR %	-	17.57	6.85	16.47	12.38